{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:07:19Z","timestamp":1761894439431},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.leukres.2006.11.001","type":"journal-article","created":{"date-parts":[[2006,12,7]],"date-time":"2006-12-07T18:01:58Z","timestamp":1165514518000},"page":"791-797","source":"Crossref","is-referenced-by-count":7,"title":["Soluble phosphorylated fms-like tyrosine kinase"],"prefix":"10.1016","volume":"31","author":[{"given":"F.","family":"Ravandi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Jilani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Estey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kantarjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Jitkaroon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Giles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Keating","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Albitar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.leukres.2006.11.001_bib1","first-page":"1641","article-title":"Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR\/CSF1R family","volume":"6","author":"Rosnet","year":"1991","journal-title":"Oncogene"},{"issue":"20","key":"10.1016\/j.leukres.2006.11.001_bib2","doi-asserted-by":"crossref","first-page":"9026","DOI":"10.1073\/pnas.88.20.9026","article-title":"A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit","volume":"88","author":"Matthews","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.leukres.2006.11.001_bib3","first-page":"595","article-title":"Hematopoietic receptors of class III receptor-type tyrosine kinases","volume":"4","author":"Rosnet","year":"1993","journal-title":"Crit Rev Oncogene"},{"issue":"5","key":"10.1016\/j.leukres.2006.11.001_bib4","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1182\/blood-2002-02-0492","article-title":"The roles of FLT3 in hematopoiesis and leukemia","volume":"100","author":"Gilliland","year":"2002","journal-title":"Blood"},{"issue":"6472","key":"10.1016\/j.leukres.2006.11.001_bib5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/368643a0","article-title":"Ligand for FLT3\/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs","volume":"368","author":"Hannum","year":"1994","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.leukres.2006.11.001_bib6","first-page":"1212","article-title":"Expression of the flt3 receptor and its ligand on hematopoietic cells","volume":"9","author":"Brasel","year":"1995","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.leukres.2006.11.001_bib7","first-page":"588","article-title":"Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells","volume":"10","author":"Drexler","year":"1996","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.leukres.2006.11.001_bib8","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1182\/blood.V88.9.3383.bloodjournal8893383","article-title":"FLT3 receptor expression on the surface of normal and malignant human hematopoietic cells","volume":"88","author":"Turner","year":"1996","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2006.11.001_bib9","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1182\/blood.V80.10.2584.2584","article-title":"Expression of the FMS\/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages","volume":"80","author":"Birg","year":"1992","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2006.11.001_bib10","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1182\/blood.V87.3.1089.bloodjournal8731089","article-title":"Expression of the hematopoietic growth factor receptor FLT3 (STK-1\/Flk2) in human leukemias","volume":"87","author":"Carow","year":"1996","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2006.11.001_bib11","first-page":"1584","article-title":"Expression of type III receptor tyrosine kinases FLT3 and KIT and responses to their ligands by acute myeloid leukemia blasts","volume":"10","author":"Stacchini","year":"1996","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.leukres.2006.11.001_bib12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood-2003-06-1969","article-title":"FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells","volume":"103","author":"Zheng","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2006.11.001_bib13","first-page":"535","article-title":"Modulation of cellular signaling pathways: prospects for targeted therapy in hematological malignancies","volume":"9","author":"Ravandi","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.leukres.2006.11.001_bib14","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/sj.leu.2403099","article-title":"FLT3: ITDoes matter in leukemia","volume":"17","author":"Levis","year":"2003","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.leukres.2006.11.001_bib15","first-page":"1911","article-title":"Internal tandem duplication of the flt3 gene found in acute myeloid leukemia","volume":"10","author":"Nakao","year":"1996","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.leukres.2006.11.001_bib16","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1182\/blood.V99.12.4326","article-title":"Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis","volume":"99","author":"Thiede","year":"2002","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2006.11.001_bib17","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1182\/blood.V97.8.2434","article-title":"Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies","volume":"97","author":"Yamamoto","year":"2001","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2006.11.001_bib18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1365-2141.2000.02317.x","article-title":"FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group","volume":"111","author":"Abu-Duhier","year":"2000","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.leukres.2006.11.001_bib19","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1046\/j.1365-2141.2001.02850.x","article-title":"Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia","volume":"113","author":"Abu-Duhier","year":"2001","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.leukres.2006.11.001_bib20","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1182\/blood-2004-02-0712","article-title":"Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML","volume":"104","author":"Jiang","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2006.11.001_bib21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood-2004-02-0660","article-title":"Identification of a novel activating mutation (Y842C) within the activation loop of FLT3 in patients with acute myeloid leukemia (AML)","volume":"105","author":"Kindler","year":"2005","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.leukres.2006.11.001_bib22","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/sj.onc.1205332","article-title":"Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domain","volume":"21","author":"Kiyoi","year":"2002","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.leukres.2006.11.001_bib23","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1182\/blood-2002-05-1440","article-title":"Prognostic significance of activating FLT3 mutations in younger adults (16\u201360 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm","volume":"100","author":"Frohling","year":"2002","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2006.11.001_bib24","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1182\/blood.V98.6.1752","volume":"98","author":"Kottaridis","year":"2001","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2006.11.001_bib25","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1182\/blood-2003-01-0137","article-title":"Activating mutations of RTK\/ras signal transduction pathway in pediatric acute myeloid leukemia","volume":"102","author":"Meshinchi","year":"2003","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2006.11.001_bib26","first-page":"3074","article-title":"Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia","volume":"93","author":"Kiyoi","year":"1999","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2006.11.001_bib27","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1182\/blood.V98.3.885","article-title":"A FLT3 tyrosine kinase inhibitor is selectively cytotoxic to acute myeloid leukemia blasts harboring FLT3 internal tandem duplication mutations","volume":"98","author":"Levis","year":"2001","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2006.11.001_bib28","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1182\/blood-2003-11-3775","article-title":"Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia","volume":"103","author":"Smith","year":"2004","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.leukres.2006.11.001_bib29","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1158\/1078-0432.CCR-04-0210","article-title":"Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3","volume":"10","author":"Bali","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.leukres.2006.11.001_bib30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1182\/blood-2004-03-0891","article-title":"Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412","volume":"105","author":"Stone","year":"2005","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2006.11.001_bib31","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1182\/blood-2006-04-015560","article-title":"A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy","volume":"108","author":"Knapper","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2006.11.001_bib32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/sj.leu.2402743","article-title":"Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNA","volume":"17","author":"Jilani","year":"2003","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.leukres.2006.11.001_bib33","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1182\/blood.V95.12.3758","article-title":"CD40-ligand stimulates myelopoiesis by regulating flt3-ligand and thrombopoietin production in bone marrow stromal cells","volume":"95","author":"Solanilla","year":"2000","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2006.11.001_bib34","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1046\/j.1365-2141.2000.01831.x","article-title":"Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells","volume":"108","author":"Fenski","year":"2000","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.leukres.2006.11.001_bib35","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","article-title":"The importance of diagnostic cytogenetics on outcome in AML: analysis of 1, 612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties","volume":"92","author":"Grimwade","year":"1998","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2006.11.001_bib36","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2006.11.001_bib37","first-page":"1368","article-title":"Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines","volume":"9","author":"Meierhoff","year":"1995","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.leukres.2006.11.001_bib38","first-page":"238","article-title":"Human FLT3\/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells","volume":"10","author":"Rosnet","year":"1996","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.leukres.2006.11.001_bib39","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1182\/blood.V86.11.4105.bloodjournal86114105","article-title":"Effects of human FLT3 ligand on myeloid leukemia cell growth: heterogeneity in response and synergy with other hematopoietic growth factors","volume":"86","author":"Piacibello","year":"1995","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2006.11.001_bib40","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1182\/blood.V88.10.3987.bloodjournal88103987","article-title":"Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax","volume":"88","author":"Lisovsky","year":"1996","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2006.11.001_bib41","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1038\/sj.leu.2401905","article-title":"Constitutive activation of FLT3 stimulates multiple intracellular signal transducers and results in transformation","volume":"14","author":"Tse","year":"2000","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.leukres.2006.11.001_bib42","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1182\/blood.V96.12.3907","article-title":"Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways","volume":"96","author":"Mizuki","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2006.11.001_bib43","first-page":"563","article-title":"Oral PKC 412 has activity in patients (pts) with mutant FLT3 acute myeloid leukemia (AML): a phase II trial","volume":"22","author":"Stone","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"7","key":"10.1016\/j.leukres.2006.11.001_bib44","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1182\/blood-2002-02-0420","article-title":"Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors","volume":"100","author":"Kottaridis","year":"2002","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.leukres.2006.11.001_bib45","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMoa031046","article-title":"Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia","volume":"350","author":"Bullinger","year":"2004","journal-title":"N Engl J Med"},{"issue":"28","key":"10.1016\/j.leukres.2006.11.001_bib46","article-title":"Novel mutations in the FLT3 gene in adult patients with refractory acute myeloid leukemia","volume":"10","author":"Choi","year":"2004","journal-title":"Leukemia"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212606004279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212606004279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T06:03:14Z","timestamp":1587276194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212606004279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0145212606004279"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2006.11.001","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}